Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized open-label crossover study of Frisium versus Yinuosi in Lennox-Gastaut syndrome
CTR20243975Phase 4Completed
- Sponsor
- Yichang Humanwell Pharmaceutical Co., Ltd.
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clobazam in Lennox-Gastaut syndrome (LGS), sponsored by Yichang Humanwell Pharmaceutical Co., Ltd.. Started Jan 2025; status: completed.
02
Drugs
clobazam
03
Conditions
Lennox-Gastaut syndrome (LGS)
Beyond the preview
Go deeper on CTR20243975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243975.